Jick, H <br/><br/>
The risk of sulfasalazine- and mesalazine-associated blood disorders.  [electronic resource] 

 -  Pharmacotherapy   
 - 176-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0277-0008 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Agranulocytosis--chemically induced<br/>Aminosalicylic Acids--adverse effects<br/>Anti-Inflammatory Agents, Non-Steroidal--adverse effects<br/>Arthritis--drug therapy<br/>Child<br/>Child, Preschool<br/>Female<br/>Follow-Up Studies<br/>Hematologic Diseases--chemically induced<br/>Humans<br/>Infant<br/>Inflammatory Bowel Diseases--drug therapy<br/>Male<br/>Mesalamine<br/>Middle Aged<br/>Product Surveillance, Postmarketing<br/>Risk Factors<br/>Sulfasalazine--adverse effects<br/>United Kingdom--epidemiology